GuangZhou Doublle Biotech successfully passed the CNAS regular supervision and expansion review
Recently, the Biological Testing Center of Guangzhou Dabo Biological Products Co., Ltd. successfully passed the regular supervision review and testing capability expansion review conducted by the China National Accreditation Service for Conformity Assessment (CNAS), becoming the first biotesting institution in Guangzhou to receive CNAS accreditation in the field of cell and gene products. This marks a new stage for the company in terms of testing capabilities and quality management systems.
CNAS Certification
It is noteworthy that the newly added testing items for cell and gene products, such as cell counting, cell phenotyping, and exogenous viral factors, belong to scarce fields where industry certification is difficult and few institutions have obtained certification. This not only demonstrates that Dabo Biotech’s technical strength in the field of cell testing has ranked among the top in the industry, but also provides authoritative qualification guarantees for the company to expand into new service areas nationwide.
The implementation of the CNAS testing capability expansion has laid a crucial technical foundation for the research, development, and commercialization of Dabo Biotech’s innovative anti-tumor drugs. At the same time, it has significantly propelled the company’s progress in stem cell and immune cell drug research and development, cell preparation and production, as well as the commercialization of technological applications. Looking ahead, Dabo Biotech will continue to refine its laboratory quality management system, deepen cell testing technology innovation, leverage its scarce certification advantages, actively expand the national market, and provide high-standard, multi-field testing services to more biopharmaceutical enterprises. By harnessing innovative strength to drive the development of new quality productivity, it aims to inject strong momentum into the upgrading of the biopharmaceutical industry in the Guangdong-Hong Kong-Macao Greater Bay Area and beyond.
